Cambridge Healthtech Institute’s 6th Annual

Next-Generation Induced Proximity Modulators

Innovative Chemistries and Assays for Driving Covalent and Proximity-Triggered Interactions

April 19, 2027


Chemically-induced proximity is an emerging strategy for developing new therapies, and covalent chemistries are often being leveraged to trigger proximity-driven degradation, stabilization, localization, folding, post-translational modifications (PTMs) or disruption of protein-protein interactions. Cambridge Healthtech Institute’s symposium on Next-Generation Induced Proximity Modulators brings together academic and industry scientists from medicinal chemistry, chemical biology, assay development, proteomics, and more to discuss innovative chemistries and technologies for leveraging proximity-driven therapeutic intervention. This symposium is a precursor to what will be discussed in the conferences on Degraders and Glues, and Protein-Protein Interactions that follow.

Coverage will likely include:

  • Induced-proximity approaches to tackle difficult-to-drug targets for therapeutic interventions
  • Utilizing innovative covalent chemistries and linker optimization for inducing proximity
  • Developments in proximity-inducing modalities for degradation and non-degrader applications
  • Use of proximity inducers for dissecting kinetics and mechanisms of binding and PTMs
  • Proximity-induced protein and peptide therapeutics
  • Advances in AI models and tools for predicting chemically-induced proximity
  • Direct-to-biology and phenotype-first proximity-driven drug discovery

The deadline for priority consideration is October 5, 2026.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation:


For more details on the conference, please contact:
Tanuja Koppal, PhD
Senior Conference Director
Cambridge Healthtech Institute
Email: tkoppal@healthtech.com

For sponsorship information, please contact:
Kristin Skahan
Senior Business Development Manager
Cambridge Healthtech Institute
Phone: (+1) 781-972-5431
Email: kskahan@healthtech.com


Register Early for Maximum Savings

APRIL 19

Covalent & Induced Proximity-Based Therapies

RNA-Modulating Small Molecule Drugs

Generative AI for Drug Discovery

training seminars

View In-Person Short Courses

APRIL 20 - 21

Degraders & Molecular Glues - Part 1

Small Molecule Discovery Technologies

AI/ML for Early Drug Discovery - Part 1

Linker & Conjugation Chemistries

Peptides

APRIL 21 - 22

Degraders & Molecular Glues - Part 2

Protein-Protein Interactions / Difficult Targets

AI/ML for Early Drug Discovery - Part 2

DNA-Encoded Libraries

GLP1 & Oral Peptides


Drug Discovery Chemsitry Europe

View All Sponsors

View All Media Partners